← Open Payments lookup

IRINA DAUPHINEE: Open Payments

NPI 1417132259 · HANOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,987 in 97 payments from 10 companies in 2025. Trend: 2023 $6,282 · 2024 $3,211 · 2025 $4,987

Food & beverage: $4,987
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$962
Otsuka America Pharmaceutical, Inc.19$897
E.R. Squibb & Sons, L.L.C.12$761
Teva Pharmaceuticals USA, Inc.13$676
Janssen Pharmaceuticals, Inc10$546
ABBVIE INC.7$369
Axsome Therapeutics, Inc.3$256
Alkermes, Inc.2$212
Neurocrine BioSciences, Inc.2$195
ACADIA Pharmaceuticals Inc2$111

Products named: CAPLYTA, REXULTI, COBENFY, UZEDY, INVEGA SUSTENNA, VRAYLAR, INGREZZA, Auvelity.

Industry payments across MA — which companies pay providers there.